TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling

被引:312
作者
Ishida, T
Tojo, T
Aoki, T
Kobayashi, N
Ohishi, T
Watanabe, T
Yamamoto, T
Inoue, J
机构
[1] UNIV TOKYO,INST MED SCI,DEPT ONCOL,MINATO KU,TOKYO 108,JAPAN
[2] UNIV TOKYO,INST MED SCI,DEPT PATHOL,MINATO KU,TOKYO 108,JAPAN
关键词
signal transduction; protein-protein interaction; yeast two-hybrid system;
D O I
10.1073/pnas.93.18.9437
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Signals emanating from CD40 play crucial roles in B-cell function, To identify molecules that transduce CD40 signalings, we have used the yeast two-hybrid system to clone cDNAs encoding proteins that bind the cytoplasmic tail of CD40. A cDNA encoding a putative signal transducer protein, designated TRAF5, has been molecularly cloned. TRAF5 has a tumor necrosis factor receptor-associated factor (TRAF) domain in its carboxyl terminus and is most homologous to TRAF3, also known as CRAF1, CD40bp, or LAP-1, a previously identified CD40-associated factor. The amino terminus has a RING finger domain, a cluster of zinc fingers and a coiled-coil domain, which are also present in other members of the TRAF family protein except for TRAF1. In vitro binding assays revealed that TRAF5 associates with the cytoplasmic tail of CD40, but not with the cytoplasmic tail of tumor receptor factor receptor type 2, which associates with TRAF2. Based on analysis of the association between TRAF5 and various CD40 mutants, residues 230-269 of CD40 are required for the association with TRAF5. In contrast to TRAF3, overexpression of TRAF5 activates transcription factor nuclear factor kappa B. Furthermore, amino-terminally truncated forms of TRAF5 suppress the CD40-mediated induction of CD23 expression, as is the case with TRAF3. These results suggest that TRAF5 and TRAF3 could be involved in both common and distinct signaling pathways emanating from CD40.
引用
收藏
页码:9437 / 9442
页数:6
相关论文
共 52 条
  • [1] MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40
    ARMITAGE, RJ
    FANSLOW, WC
    STROCKBINE, L
    SATO, TA
    CLIFFORD, KN
    MACDUFF, BM
    ANDERSON, DM
    GIMPEL, SD
    DAVISSMITH, T
    MALISZEWSKI, CR
    CLARK, EA
    SMITH, CA
    GRABSTEIN, KH
    COSMAN, D
    SPRIGGS, MK
    [J]. NATURE, 1992, 357 (6373) : 80 - 82
  • [2] STRUCTURE OF THE C3HC4 DOMAIN BY H-1-NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY - A NEW STRUCTURAL CLASS OF ZINC-FINGER
    BARLOW, PN
    LUISI, B
    MILNER, A
    ELLIOTT, M
    EVERETT, R
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1994, 237 (02) : 201 - 211
  • [3] BERBERICH I, 1994, J IMMUNOL, V153, P4357
  • [4] A NOVEL PROTEIN THAT INTERACTS WITH THE DEATH DOMAIN OF FAS/APO1 CONTAINS A SEQUENCE MOTIF RELATED TO THE DEATH DOMAIN
    BOLDIN, MP
    VARFOLOMEEV, EE
    PANCER, Z
    METT, IL
    CAMONIS, JH
    WALLACH, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) : 7795 - 7798
  • [5] CAMERINI D, 1991, J IMMUNOL, V147, P3165
  • [6] MOLECULAR DEFINITION AND SEQUENCE MOTIFS OF THE 52-KD COMPONENT OF HUMAN SS-A/RO AUTOANTIGEN
    CHAN, EKL
    HAMEL, JC
    BUYON, JP
    TAN, EM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (01) : 68 - 76
  • [7] INVOLVEMENT OF CRAF1, A RELATIVE OF TRAF, IN CD40 SIGNALING
    CHENG, GH
    CLEARY, AM
    YE, ZS
    HONG, DI
    LEDERMAN, S
    BALTIMORE, D
    [J]. SCIENCE, 1995, 267 (5203) : 1494 - 1498
  • [8] FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS
    CHINNAIYAN, AM
    OROURKE, K
    TEWARI, M
    DIXIT, VM
    [J]. CELL, 1995, 81 (04) : 505 - 512
  • [9] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [10] PROLIFERATION AND DIFFERENTIATION OF HUMAN CD5+ AND CD5- B-CELL SUBSETS ACTIVATED THROUGH THEIR ANTIGEN RECEPTORS OR CD40-ANTIGENS
    DEFRANCE, T
    VANBERVLIET, B
    DURAND, I
    BRIOLAY, J
    BANCHEREAU, J
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (11) : 2831 - 2839